Correspondence 0001193125-22-281349 from IGM Biosciences, Inc. (IGMS) (CIK 0001496323)
IGM Biosciences, Inc. (IGMS) (CIK 0001496323)
Date: Nov. 9, 2022 · CIK: 0001496323 · Accession: 0001193125-22-281349
AI Filing Summary & Sentiment
File numbers found in text: 333-268136
Letter
325 E Middlefield Road
Mountain View, CA 94043
(650) 965-7873
November 9, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Healthcare & Insurance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Jimmy McNamara
Re:
IGM Biosciences, Inc.
Registration Statement on Form S-3
File No. 333-268136
Acceleration Request
Requested Date: November 14, 2022
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, IGM Biosciences, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-268136) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Jennifer Knapp at (650) 849-3041.
[Signature page follows]
Securities and Exchange Commission
November 9, 2022
Page
Sincerely,
IGM BIOSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
325 E Middlefield Road
Mountain View, CA 94043
(650) 965-7873
November 9, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division
of Corporation Finance
Office of Healthcare & Insurance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Jimmy McNamara
Re:
IGM Biosciences, Inc.
Registration Statement on Form S-3
File No. 333-268136
Acceleration Request
Requested Date: November 14, 2022
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, IGM Biosciences, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-268136) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its
counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our
counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Jennifer Knapp at (650) 849-3041.
[Signature page follows]
Securities and Exchange Commission
November 9, 2022
Page
2
Sincerely,
IGM BIOSCIENCES, INC.
/s/ Paul Graffagnino
Paul Graffagnino
Vice President, Legal Affairs
cc:
Fred Schwarzer, IGM Biosciences, Inc.
Misbah Tahir, IGM Biosciences, Inc.
Tony Jeffries, Wilson Sonsini Goodrich & Rosati, P.C.
Kenneth A. Clark, Wilson Sonsini Goodrich & Rosati, P.C.
Jennifer Knapp, Wilson Sonsini Goodrich & Rosati, P.C.
Christina Poulsen, Wilson Sonsini Goodrich & Rosati, P.C.
www.igmbio.com |
info@igmbio.com